What is compounded semaglutide?

If you have researched medical weight management, you have probably seen the word compounded attached to semaglutide, and it is not always clear what that means. Is it the same as the brand-name products? Is it safe? Who decides whether you can have it? This article explains what compounded semaglutide actually is, in plain language, so you can have a more informed conversation with a licensed clinician.

This is patient education, not medical advice. Whether any medication is appropriate for you is a decision only an independent licensed medical professional can make, based on your individual health.

What semaglutide is and how GLP-1 medications work

Semaglutide belongs to a class of medicines called GLP-1 receptor agonists. GLP-1, glucagon-like peptide-1, is a hormone your body releases after you eat. It plays a role in appetite and in blood sugar regulation: it helps signal fullness, slows how quickly the stomach empties, and supports the release of insulin when blood sugar rises.

A GLP-1 receptor agonist is a medicine designed to mimic that hormone. By acting on the same receptors, semaglutide can influence appetite signalling and the sense of satiety. Many people describe feeling satisfied sooner and staying full for longer. That is why it is used in the context of type 2 diabetes and, separately, chronic weight management, but it is important to understand that it is intended to work alongside a reduced-calorie diet and increased physical activity, not as a replacement for them.

It also helps to be realistic about what a medication in this class is and is not. It is a clinical tool that can support a broader plan; it is not a shortcut, and individual responses vary. A responsible programme pairs any medication with guidance on nutrition, activity, and long-term habits, because the medicine addresses only one part of a much bigger picture.

You may recognise semaglutide by its FDA-approved brand names. Ozempic® (semaglutide) is FDA-approved for type 2 diabetes, and Wegovy® (semaglutide) is FDA-approved for chronic weight management. These are manufactured, branded products with FDA-reviewed labeling. Compounded semaglutide is a different thing, which is where the distinction matters.

What “compounded” means, and why compounded semaglutide exists

Compounding is the practice of a licensed pharmacy preparing a medication for an individual patient, rather than dispensing a mass-manufactured product straight from the box. Compounding has a long, legitimate history in U.S. pharmacy, for example, preparing a formulation for someone who is allergic to an ingredient in a standard version, or who needs a different form.

You may also see two categories referenced. A 503A pharmacy compounds medications for individual patients pursuant to a prescription. A 503B outsourcing facility operates under different federal oversight and can produce larger batches. Lovely Meds works with 503A-licensed compounding pharmacies that hold substance-specific approval. In every case, the compounding pharmacy's licensing and quality standards are central to what you receive.

Here is the essential point, and it is one worth reading twice: compounded medications, including compounded semaglutide, are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality. That does not automatically mean they cannot be prescribed, it means the specific compounded preparation has not gone through the FDA review that a brand-name product has.

So why does compounded semaglutide exist at all? A significant reason has been supply. When the FDA lists a medication in shortage, compounding pharmacies may, under certain conditions, prepare versions to help meet patient need, and demand for GLP-1 medicines has at times outstripped the available branded supply. The FDA's shortage status for a given product can change over time, which is one reason clinical decisions are made case by case rather than by a fixed rule, the FDA declared the semaglutide shortage resolved in February 2025, which began a wind-down of routine compounding. The rules also differ sharply outside the US, as set out in this analysis of the US–UK regulatory divergence. More broadly, an independent licensed physician may determine that a compounded formulation is appropriate for a specific patient to meet a particular clinical need. In other words, compounded versions may be prescribed by independent licensed physicians when clinically appropriate, such as during an FDA-declared shortage or to meet specific patient needs.

It is also worth understanding what compounding is not. It is not a generic version of a brand-name drug, true generics are themselves FDA-approved and are held to bioequivalence standards. And a compounded preparation is only as reliable as the pharmacy that prepares it, which is why the licensing and standards of that pharmacy matter a great deal.

How compounded semaglutide is prescribed and dispensed

Access to any prescription treatment through a responsible telehealth service follows a clear path, and it always begins with a clinician, never with a checkout. At The Lovely Meds Journal's parent company, and at legitimate services generally, the sequence looks like this:

1. An online evaluation. You complete a confidential questionnaire about your health history, current medications, allergies, and goals. Accuracy here matters, because it is what the clinician relies on.
2. Clinician review. An independent, licensed medical professional reviews your information and determines whether treatment is appropriate for you. This is a genuine clinical judgement, starting an evaluation does not guarantee that anything will be prescribed, and a responsible clinician will decline when treatment is not suitable.
3. Dispensing by a licensed pharmacy. If a compounded medication is prescribed, it is prepared and dispensed by a licensed compounding pharmacy. Reputable services work with pharmacies that hold the appropriate state licensure and operate under 503A regulatory standards.
4. Ongoing support and follow-up. Treatment is typically started at a low dose and adjusted gradually over time under clinical guidance, with check-ins to review how you are tolerating it.

Two things are worth emphasising. First, the prescriber is independent and licensed, the clinical decision is theirs, based on your evaluation, not on what you ask to buy. Second, the medication is dispensed through a licensed pharmacy, not sold as a consumer product.

That distinction is also how you separate a legitimate service from a risky one. Warning signs include a website that will sell you semaglutide with no evaluation and no clinician involved, that ships from unverified overseas sources, that makes dramatic promises, or that cannot tell you which licensed pharmacy prepares the medication. If obtaining a prescription medicine feels as frictionless as buying a phone case, something is wrong.

You can read more about how our content is reviewed and the standards we hold on our About the Journal page, and you can explore related explainers in Weight Management.

Questions worth asking before you start

Whatever you decide, going into a consultation prepared makes it more useful. A few questions worth raising with a licensed clinician:

• Based on my health history, is a GLP-1 medication a reasonable option for me at all?
• What are the specific risks and side effects I should watch for, and what should I do if they occur?
• Which licensed pharmacy would prepare the medication, and what are its standards?
• How will my dose be started and adjusted, and how will we monitor how I am doing?
• What lifestyle support comes with treatment, and what should I expect the medication to do, and not do?

Good answers to these questions are a sign you are dealing with a service that treats you as a patient rather than a customer.

Safety, side effects, and talking to a clinician

Like all medicines, semaglutide can cause side effects. The most commonly reported are gastrointestinal: nausea, diarrhea, vomiting, constipation, abdominal pain, indigestion, and fatigue. For many people these are mild and tend to ease over time, particularly as the dose is adjusted gradually, but they are real, and they are worth discussing with your clinician before you start.

There are also more serious warnings that everyone considering a GLP-1 medication should be aware of, including a boxed warning relating to thyroid C-cell tumors observed in rodent studies. These medicines are not appropriate for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and there are important cautions around pancreatitis, gallbladder disease, kidney problems, and pregnancy. The Important Safety Information below summarises these, and your clinician will review your specific history in detail.

With compounded semaglutide specifically, there is an added layer to keep in mind: because the preparation is not FDA-approved, the assurance of quality rests on the licensing and standards of the compounding pharmacy rather than on FDA review. This is one of the reasons that who you obtain treatment through matters as much as what you obtain. Authoritative sources such as the U.S. Food and Drug Administration (fda.gov) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) publish general information on GLP-1 medicines and on compounding that is worth reading alongside a clinician's advice.

The bottom line

Compounded semaglutide is a preparation of a GLP-1 medication made by a licensed pharmacy for an individual patient. It shares its active molecule with the FDA-approved brands, but it is not itself FDA-approved, and it should only ever be obtained through an evaluation with an independent licensed clinician and dispensed by a licensed pharmacy.

No article can tell you whether it is right for you, and any source that promises a specific result should be treated with caution. What a good evaluation can do is weigh your health, your history, and your goals, and let an independent licensed clinician make that decision with you.

Frequently asked questions